PDS0101 and pembrolizumab combination achieved a median overall survival of 39.3 months in HPV16-positive head and neck cancer patients with a CPS of at least 1. The VERSATILE-002 trial showed ...

A new report has laid bare how head and neck cancers have "persistently poor" survival rates in our region.

Add Yahoo as a preferred source to see more of our stories on Google. (WKBN) – A new report from the American Cancer Society shows cancer survival rates here in the U.S. have reached a new milestone.

Cancer statistics have reached new heights — in good and not-so-good ways. The American Cancer Society (ACS) released its annual report on cancer trends this week, showing for the first time that more ...

Head and neck cancer (HNC) represents a significant global health challenge, characterized by aggressive local invasion, frequent recurrence, and poor survival rates. Beyond its physical burden, HNC ...

No matter which side of the political spectrum you sit on, good news can feel hard to come by these days — which is why the most recent annual report from the American Cancer Society is such a boon.

LOUISVILLE, Ky. (WDRB) -- According to the American Cancer Society, people with cancer are living longer than ever before. The organization credited large advancements in cancer research. "This is one ...

Less-invasive robotic surgery for upper airway and digestive track malignant tumors is as effective as other minimally invasive surgical techniques based on patient function and survival, according to ...